Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-effectiveness of radiologist reading of chest CT scans assisted by software with artificial intelligence-derived algorithms for the detection and analysis of lung nodules.

BJR artificial intelligence·2026

Same author

Methods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review.

Health technology assessment (Winchester, England)·2026

Same author

Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews.

Health technology assessment (Winchester, England)·2025

Same author

Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers.

BMJ medicine·2025

Same author

FAST MRI: DYAMOND trial protocol (can an abbreviated MRI scan detect breast cancers missed by mammography for screening clients with average mammographic density attending their first screening mammogram?)-a diagnostic yield study within the NHS population-risk breast screening programme.

BMJ open·2025

Same author

Determining optimal strategies for primary prevention of cardiovascular disease: a synopsis of an evidence synthesis study.

Health technology assessment (Winchester, England)·2025

Same journal

Audit and feedback in primary care: if you build it, will they come? Understanding which clinicians engage with an audit and feedback intervention.

BMJ quality & safety·2026

Same journal

Brief mindfulness-based intervention to improve clinician mindful behaviours and well-being at two US hospitals: a randomised controlled, mixed methods trial.

BMJ quality & safety·2026

Same journal

Paradox of engagement: precautionary public health alerts and gender inequality in cancer diagnosis-a quasi-experimental study.

BMJ quality & safety·2026

Same journal

Priorities for improving paediatric diagnosis: findings from a modified Delphi study.

BMJ quality & safety·2026

Same journal

Development and pilot evaluation of the implementation of a whole-team training pack to improve the effectiveness, efficiency, safety and equity of remote general practice.

BMJ quality & safety·2026

Same journal

Mapping Theories, Models and Frameworks from implementation science for evaluating quality improvement initiatives: a scoping review.

BMJ quality & safety·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 6, 2025

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

The problem with uptake as a quality metric for population-based screening programmes

Natalie Armstrong¹, Sian Taylor-Phillips²

¹Department of Population Health Sciences, University of Leicester, Leicester, UK Natalie.Armstrong@le.ac.uk.

BMJ Quality & Safety

|November 26, 2024

Summary

No abstract available in PubMed .

Keywords:

Health services research Performance measures Quality measurement

More Related Videos

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Related Experiment Videos

Last Updated: Jun 6, 2025

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012